Atlas Trials

Pharmacokinetic and Pharmacodynamic Effects of Escitalopram Depending on Genetic Polymorphisms of the ABCB1-gene

Clinical trial NCT00550485 · COMPLETED

Trial details

NCT number
NCT00550485
Sponsor
Max-Planck-Institute of Psychiatry
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Pharmacokinetics
Start date
2007-10-01
Primary completion
2018-07-06
Enrollment
79

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.